Shares of Su Xuan Tang (SXTC, Financial) experienced a significant drop, falling by 5.45% to $0.572 per share with a trading volume of 133,332 shares and a turnover rate of 3.84%. The stock's fluctuation rate was reported at 5.12%.
Recent financial reports reveal the company generated $1.93 million in revenue but suffered a net loss of $3.10 million, equating to an earnings per share of -$3.57. Gross profit stood at $553,971, and the price-to-earnings ratio was -0.16. Currently, there are no institutional ratings offering a buy, hold, or sell recommendation for SXTC.
Within the broader pharmaceutical sector, which rose by 0.37%, other stocks showed notable movements. Stocks such as Biofrontera Inc., Mira Pharmaceuticals, Inc., and Petros Pharmaceuticals, Inc. posted significant gains, while Akanda Corp., Canopy Growth Corporation, and Painreform Ltd. remained active. Biofrontera Inc. also had the highest volatility with a 30.00% swing.
Su Xuan Tang specializes in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), focusing on ready-to-use forms of TCMP without the need for decoction. The company's revenue originates from China.
